Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Lincoln Pharmaceuticals Ltd.

Aug 05, 02:06 BSE 533.90 ( -0.35 -0.07%)

Volume2675

Prev. Close
534.25

Open Price
532.50

Today's Low / High

526.05 537.30

Bid. Price (Qty.)532.50 (7)

Offer Price (Qty.)
533.95 (1)

52 Wk Low / High

500.00 975.00

Aug 05, 01:54 NSE 532.50(+ 0.90 0.17%)

Volume10526

Prev. Close
531.60

Open Price
530.00

Today's Low / High

529.00 536.35

Bid Price (Qty.)532.50 (5)

Offer Price (Qty.) 533.25 (1)

52 Wk Low / High

499.00 979.50

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	623.23	571.22	504.95	468.20	414.75
Other Operating Revenues	0.00	9.33	5.35	3.93	9.44
Total Operating Revenues	623.23	580.55	510.31	472.12	424.19

Other Income	22.48	34.42	22.47	10.00	5.66
Total Revenue	645.71	614.97	532.78	482.12	429.85

EXPENSES
Cost Of Materials Consumed	213.94	201.12	177.00	158.48	123.43
Purchase Of Stock-In Trade	68.54	82.91	68.64	73.67	70.31
Changes In Inventories Of FG,WIP And Stock-In Trade	8.84	-5.70	-4.24	-13.57	3.99
Employee Benefit Expenses	112.45	102.90	93.16	70.47	60.74
Finance Costs	1.88	1.46	2.03	1.45	1.56
Depreciation And Amortisation Expenses	12.90	10.62	9.17	8.09	7.56
Other Expenses	117.96	99.40	86.55	87.59	78.53
Total Expenses	536.52	492.73	432.30	386.18	346.13

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	109.19	122.24	100.48	95.94	83.72

Profit/Loss Before Tax	109.19	122.24	100.48	95.94	83.72

Tax Expenses-Continued Operations
Current Tax	26.84	25.21	24.75	24.50	21.29
Deferred Tax	0.00	3.49	1.59	0.72	0.25
Tax For Earlier Years	0.00	0.24	1.24	1.37	-0.07
Total Tax Expenses	26.84	28.94	27.58	26.58	21.47
Profit/Loss After Tax And Before ExtraOrdinary Items	82.35	93.30	72.90	69.36	62.25

Profit/Loss From Continuing Operations	82.35	93.30	72.90	69.36	62.25

Profit/Loss For The Period	82.35	93.30	72.90	69.36	62.25

Minority Interest	0.00	0.00	0.00	0.00	-0.03
Consolidated Profit/Loss After MI And Associates	82.35	93.30	72.90	69.36	62.22

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	41.11	46.58	36.40	34.63	31.11
Diluted EPS (Rs.)	41.11	46.58	36.40	34.63	31.11

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	3.00	3.00	3.00	0.00

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	623.23
Other Operating Revenues	0.00
Total Operating Revenues	623.23
Other Income	22.48
Total Revenue	645.71
EXPENSES
Cost Of Materials Consumed	213.94
Purchase Of Stock-In Trade	68.54
Changes In Inventories Of FG,WIP And Stock-In Trade	8.84
Employee Benefit Expenses	112.45
Finance Costs	1.88
Depreciation And Amortisation Expenses	12.90
Other Expenses	117.96
Total Expenses	536.52
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	109.19
Profit/Loss Before Tax	109.19
Tax Expenses-Continued Operations
Current Tax	26.84
Deferred Tax	0.00
Tax For Earlier Years	0.00
Total Tax Expenses	26.84
Profit/Loss After Tax And Before ExtraOrdinary Items	82.35
Profit/Loss From Continuing Operations	82.35
Profit/Loss For The Period	82.35
Minority Interest	0.00
Consolidated Profit/Loss After MI And Associates	82.35
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	41.11
Diluted EPS (Rs.)	41.11
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00